Clinical Trials Logo

Clinical Trial Summary

This within-subject, double blind, randomized controlled study will investigate the effects of a widely used benzodiazepine (BZD), lorazepam, on various neuroimaging measures. The investigators will be assessing the relationship of lorazepam to resting state functional connectivity and other neuroimaging measures. Specifically, the investigators will be using a pre-identified metric, the striatal connectivity index (SCI), (Sarpal et al. 2015, 2016), a prognostic biomarker of treatment response assessing the connectivity between regions of the striatum and the cortex. The investigators hypothesize that lorazepam administration will be associated with greater SCI values compared with placebo administration; consistent with previous work suggesting short-acting benzodiazepines increase functional connectivity across brain networks.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04671836
Study type Interventional
Source Northwell Health
Contact
Status Withdrawn
Phase Early Phase 1
Start date January 2022
Completion date December 2022

See also
  Status Clinical Trial Phase
Completed NCT02972853 - Mindful Self-Regulation fMRI Pilot Study N/A
Completed NCT02879565 - Families Expectations and Hope Raised by an Evaluation of Consciousness in Patients in a Vegetative State N/A
Recruiting NCT03893006 - Vehicle Automation Impact on Drivers N/A
Active, not recruiting NCT02826733 - Evaluation of the Implementation of the Hemispheric Dominance During Development
Completed NCT03531580 - Comparing Brain Images Before and After MRI-upgrade - TimFit Upgrade Study N/A
Completed NCT02959489 - Risk Evaluation and Education for Alzheimer's Disease - the Study of Communicating Amyloid Neuroimaging (REVEAL-SCAN) N/A
Completed NCT03313674 - Investigation of Seasonal Variations of Brain Structure and Connectivity in SAD N/A
Recruiting NCT05776602 - Fast Brain MRI in Children With Suspected Brain Tumor
Completed NCT05262790 - The Difference of Grey Matter Volume Among the Patients of Schizophrenia
Completed NCT03501004 - The Study of Acupuncture on Vascular and Functional Neuroimaging in Parkinson's Disease Patients With Sleep Disorders N/A
Recruiting NCT05698511 - Neural and Physiological Correlates of Psychedelic Sub-states Phase 1
Not yet recruiting NCT03591315 - Clinical Study of Structural and Functional Evaluation of the Visual Pathway
Recruiting NCT04951700 - Aging and Disease Course: Contributions to Lifespan Neurobiology of Schizophrenia
Not yet recruiting NCT05140850 - Long-term Consequences of Neuroimaging and Perceived Cognitive Dysfunction in oPRES
Completed NCT01514630 - Creatine as a Treatment Option for Depression in Methamphetamine Using Females Phase 4
Completed NCT02939885 - fMRI Study of Brain Mechanisms Related to Emotions N/A
Recruiting NCT04696315 - Early Diagnosis of SCD Based on Radiogenomics
Enrolling by invitation NCT01981148 - Measurement of Retinal Auto Fluorescence With a Fluorescence Lifetime Imaging Ophthalmoscope
Completed NCT03475823 - Cognitive and Blood Flow Effects of Mountain Tea N/A
Completed NCT04135105 - Lexical Tone Perception in Tone language--a fMRI Study